Trial intelligence / Profile preview

Effect of tranexamic acid on blood loss after knee arthroplasty

IRCT201009204780N1Phase 3Completed

Sponsor
Vice Chancellor for Research of Mashhad University of Medical Sciences
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tranexamic acid in knee osteoarthritis (OA), sponsored by Vice Chancellor for Research of Mashhad University of Medical Sciences. Primary endpoint: Postoperative blood loss. Started Jan 2012; status: completed.

02

Drugs

tranexamic acid
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on IRCT201009204780N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201009204780N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call